Wednesday, 29 August 2018

LaurusLabs climbs 6% on USFDA approval


Shares of Laurus Labs climbed 6 percent on Thursday after the pharma company received USFDA approval for a generic drug used in the treatment of diabetes.The stock rose 5.84 percent to hit a high of Rs 464.35 on the BSE.For more information on stock tips and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co

Connect with our social media sites

0 comments:

Post a Comment

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Online Project management